NAMI
RARE icon

Nomura Asset Management International’s Ultragenyx Pharmaceutical RARE Stock Holding History

Nomura Asset Management International’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.94M Buy
297,819
+116,046
+64% +$2.88M 0.01% 754
2026
Q1 		$3.81M Sell
181,773
-1,035
-0.6% -$23.3K 0.01% 834
2025
Q4 		$4.21M Buy
+182,808
New +$6.01M 0.01% 828

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Nomura Asset Management International's RARE Position: Q2 2026 in Review

Nomura Asset Management International increased its Ultragenyx Pharmaceutical (RARE) stake by 64% in Q2 2026, buying an estimated $2.88M and bringing the position to 297,819 shares worth $9.94M. The position accounts for 0.01% of the portfolio, ranked #754.

Nomura Asset Management International first reported a position in RARE in Q4 2025 and has held it in 3 quarters since. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Nomura Asset Management International held 297,819 shares of Ultragenyx Pharmaceutical worth $9.94M as of Q2 2026.
  • Nomura Asset Management International bought 116,046 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $2.88M.
  • Ultragenyx Pharmaceutical made up 0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #754 holding.
  • Nomura Asset Management International first reported a position in Ultragenyx Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.